1. Home
  2. AZTR vs XELB Comparison

AZTR vs XELB Comparison

Compare AZTR & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • XELB
  • Stock Information
  • Founded
  • AZTR 2014
  • XELB 2011
  • Country
  • AZTR United States
  • XELB United States
  • Employees
  • AZTR N/A
  • XELB N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • XELB Multi-Sector Companies
  • Sector
  • AZTR Health Care
  • XELB Miscellaneous
  • Exchange
  • AZTR Nasdaq
  • XELB Nasdaq
  • Market Cap
  • AZTR 3.7M
  • XELB 3.7M
  • IPO Year
  • AZTR 2023
  • XELB N/A
  • Fundamental
  • Price
  • AZTR $0.16
  • XELB $1.08
  • Analyst Decision
  • AZTR
  • XELB
  • Analyst Count
  • AZTR 0
  • XELB 0
  • Target Price
  • AZTR N/A
  • XELB N/A
  • AVG Volume (30 Days)
  • AZTR 1.0M
  • XELB 1.4M
  • Earning Date
  • AZTR 08-11-2025
  • XELB 08-14-2025
  • Dividend Yield
  • AZTR N/A
  • XELB N/A
  • EPS Growth
  • AZTR N/A
  • XELB N/A
  • EPS
  • AZTR N/A
  • XELB N/A
  • Revenue
  • AZTR N/A
  • XELB $5,774,000.00
  • Revenue This Year
  • AZTR N/A
  • XELB $23.96
  • Revenue Next Year
  • AZTR N/A
  • XELB $53.02
  • P/E Ratio
  • AZTR N/A
  • XELB N/A
  • Revenue Growth
  • AZTR N/A
  • XELB N/A
  • 52 Week Low
  • AZTR $0.14
  • XELB $0.95
  • 52 Week High
  • AZTR $0.80
  • XELB $8.49
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 33.84
  • XELB 36.30
  • Support Level
  • AZTR $0.14
  • XELB $1.02
  • Resistance Level
  • AZTR $0.16
  • XELB $1.15
  • Average True Range (ATR)
  • AZTR 0.01
  • XELB 0.13
  • MACD
  • AZTR -0.00
  • XELB -0.00
  • Stochastic Oscillator
  • AZTR 26.81
  • XELB 17.34

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: